Format

Send to

Choose Destination
Eur J Pharm Sci. 2017 Jan 1;96:115-128. doi: 10.1016/j.ejps.2016.07.021. Epub 2016 Aug 2.

Advances of blood cell-based drug delivery systems.

Author information

1
School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
2
Department of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, Chicago, IL, 60628, USA.
3
School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China. Electronic address: mfqiu@sjtu.edu.cn.

Abstract

Blood cells, including erythrocytes, leukocytes and platelets are used as drug carriers in a wide range of applications. They have many unique advantages such as long life-span in circulation (especially erythrocytes), target release capacities (especially platelets), and natural adhesive properties (leukocytes and platelets). These properties make blood cell based delivery systems, as well as their membrane-derived carriers, far superior to other drug delivery systems. Despite the advantages, the further development of blood cell-based delivery systems was hindered by limitations in the source, storage, and mass production. To overcome these problems, synthetic biomaterials that mimic blood cell and nanocrystallization of blood cells have been developed and may represent the future direction for blood cell membrane-based delivery systems. In this paper, we review recent progress of the rising blood cell-based drug delivery systems, and also discuss their challenges and future tendency of development.

KEYWORDS:

Blood cell; Drug delivery systems; Erythrocytes; Leukocytes; Platelets

PMID:
27496050
DOI:
10.1016/j.ejps.2016.07.021
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center